Determinants of initiated and continued benzodiazepine use in the netherlands study of depression and anxiety

Journal of Clinical Psychopharmacology

Volumn 31, Issue 6, 2011, Pages 774-779

  Manthey, Leonie ^a   Giltay, Erik J ^a   Van Veen, Tineke ^a   Neven, Arie Knuistingh ^a   Zitman, Frans G ^a   Penninx, Brenda W J H ^a,b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

anxiety; benzodiazepines; diazepam; epidemiologic determinants; longitudinal studies; oxazepam

Indexed keywords

BENZODIAZEPINE;

ADULT; AGE; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; BECK ANXIETY INVENTORY; CHRONIC DISEASE; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG USE; EDUCATION; EMPLOYMENT; EXTRAVERSION; FEMALE; FOLLOW UP; GENDER; HEALTH STATUS; HUMAN; INSOMNIA; LOCUS OF CONTROL; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NEUROSIS; PAIN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION; TREATMENT WITHDRAWAL;

ADULT; AGE FACTORS; ANXIETY DISORDERS; BENZODIAZEPINES; COHORT STUDIES; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; TIME FACTORS;

EID: 80755175888     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182362484     Document Type: Article

References (38)

1. Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol. 1999;9:399-405.
2. Hollister LE, Mulleroerlinghausen B, Rickels K, et al. Clinical uses of benzodiazepines. J Clin Psychopharmacol. 1993;13:S1YS169.
3. Woods JH, Katz JL, Winger G. BenzodiazepinesVuse, abuse, and consequences. Pharmacol Rev. 1992;44:151-347.
4. Woods JH, Winger G. Current benzodiazepine issues. Psychopharmacology. 1995;118:107-115.
5. Perodeau G, Cappeliez P. Quality of life and benzodiazepine drug use by community-dwelling elderly: a stress and coping perspective. Eur Rev Appl Psychol. 2007;57:193-200.
6. Neutel CI. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry. 2005;17:189-197. (Pubitemid 40827296)
7. Donoghue J, Lader M. Usage of benzodiazepines: a review. Int J Psychiatr Clin Pract. 2010;14:78-87.
8. Shader RI, Greenblatt DJ. Drug-therapyVuse of benzodiazepines in anxiety disorders. N Engl J Med. 1993;328:1398-1405.
9. Knuistingh Neven A, Lucassen P, Bonsema K, et al. Practice guideline for insomnia and hypnotics (Dutch College of Genera; Practitioners). [In Dutch: NHG-Standaard Slapeloosheid en slaapmiddelen]. Huisarts Wetenschap. 2005;48:402-415.
10. Terluin B, van Heest F, van der Meer K, et al. NHG-Standaard Angststoornissen (eerste herziening). Huisarts Wet. 2004;47:26-37.
11. Manthey L, van VT, Giltay EJ, et al. Correlates of (inappropriate) benzodiazepine use: the Netherlands Study of Depression and Anxiety (NESDA). Br J Clin Pharmacol. 2011;71:263-272.
12. Boeuf-Cazou O, Niezborala M, Marquie JC, et al. Factors associated with psychoactive drug initiation in a sample of workers in France: results of the VISAT cohort study. Pharmacoepidemiol Drug Saf. 2010;19:296-305.
13. Bartlett G, Abrahamowicz M, Grad R, et al. Association between risk factors for injurious falls and new benzodiazepine prescribing in elderly persons. BMC Fam Pract. 2009;10:1.
14. Luijendijk HJ, Tiemeier H, Hofman A, et al. Determinants of chronic benzodiazepine use in the elderly: a longitudinal study. Br J Clin Pharmacol. 2008;65:593-599. (Pubitemid 351365131)
15. Jorm AF, Grayson D, Creasey H, et al. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Pub Health. 2000;24:7-10. (Pubitemid 30113593)
16. Dealberto MJ, Seeman T, Mcavay GJ, et al. Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol. 1997;50:357-364. (Pubitemid 27165714)
17. Gray SL, Eggen AE, Blough D, et al. Benzodiazepine use in older adults enrolled in a health maintenance organization. Am J Geriatr Psychiatry. 2003;11:568-576. (Pubitemid 37093384)
18. Isacson D. Long-term benzodiazepine use: factors of importance and the development of individual use patterns over timeYa 13-year follow-up in a Swedish community. Soc Sci Med. 1997;44: 1871-1880. (Pubitemid 27246201)
19. Simon GE, VonKorff M, Barlow W, et al. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol. 1996;49:1067-1073. (Pubitemid 26319043)
20. Barnas C, Whitworth AB, Fleischhacker WW. Are patterns of benzodiazepine use predictable-a follow-up-study of benzodiazepine users. Psychopharmacology. 1993;111:301-305. (Pubitemid 23165259)
21. Fourrier A, Letenneur L, Dartigues JF, et al. Benzodiazepine use in an elderly community-dwelling populationVcharacteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol. 2001;57:419-425. (Pubitemid 33787193)
22. Isacson D, Carsjo K, Bergman U, et al. Long-term use of benzodiazepines in a Swedish communityVan 8-year follow-up. J Clin Epidemiol. 1992;45:429-436.
23. Penninx BW, Beekman AT, Smit JH, et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res. 2008;17:121-140.
24. Penninx BW, Nolen WA, Lamers F, et al. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2011;133(1-2):76-85.
25. Riss J, Cloyd J, Gates J, et al. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008;118:69-86.
26. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD System [WHO website]. Available at: http://www.whocc.no/atc-ddd-index. Accessed March 22, 2010.
27. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893-897. (Pubitemid 19008360)
28. Levine DW, Kripke DF, Kaplan RA, et al. Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess. 2003;15:137-148. (Pubitemid 36750522)
29. Wardenaar KJ, van VT, Giltay EJ, et al. The structure and dimensionality of the Inventory of Depressive Symptomatology Self Report (IDS-SR) in patients with depressive disorders and healthy controls. J Affect Disord. 2010;125:146-154.
30. Pearlin LI, Schooler C. Structure of coping. J Health Soc Behav. 1978;19:2-21.
31. Costa PT, McCrae RR. Domains and facets: hierarchical personality assessment using the revised NEO personality inventory. J Pers Assess. 1995;64:21-50.
32. Roijen Lv, Straten Av, Tiemens B, et al. Handleiding Trimbos/iMTA questionnaire for costs associated with psychiatric illness (Tic-P [User manual]). 2002.
33. VonKorff M, Ormel J, Keefe FJ, et al. Grading the severity of chronic pain. Pain. 1992;50:133-149.
34. Babor TF, Kranzler HR, Lauerman RJ. Early detection of harmful alcohol-consumption-comparison of clinical, laboratory, and self-report screening procedures. Addict Behav. 1989;14:139-157. (Pubitemid 19157711)
35. Lyketsos CG, Nestadt G, Cwi J, et al. The Life Chart Interview: a standardized method to describe the course of psychopathology. Int J Methods Psychiatr Res. 1994;4:143-155.
36. Brugha T, Bebbington P, Tennant C, et al. The list of threatening experiences-a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med. 1985;15:189-194. (Pubitemid 15133493)
37. Zitman FG, Couvee JE. Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-offVreport on behalf of the Dutch Chronic Benzodiazepine Working Group. Br J Psychiatry. 2001;178:317-324. (Pubitemid 32280925)
38. Davidson L, Shahar G, Lawless MS, et al. Play, pleasure, and other positive life events: "non-specific" factors in recovery from mental illness? Psychiatr Int Biol Proc. 2006;69:151-163. (Pubitemid 44180783)